J. Davis Allan

1.7k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

J. Davis Allan is a scholar working on Infectious Diseases, Immunology and Pharmacology. According to data from OpenAlex, J. Davis Allan has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Immunology and 7 papers in Pharmacology. Recurrent topics in J. Davis Allan's work include T-cell and Retrovirus Studies (8 papers), HIV/AIDS drug development and treatment (7 papers) and Animal Disease Management and Epidemiology (6 papers). J. Davis Allan is often cited by papers focused on T-cell and Retrovirus Studies (8 papers), HIV/AIDS drug development and treatment (7 papers) and Animal Disease Management and Epidemiology (6 papers). J. Davis Allan collaborates with scholars based in United States, Canada and Sweden. J. Davis Allan's co-authors include Jerome E. Groopman, T R Rota, Joan C. Kaplan, Martin Hirsch, Lionel Resnick, David D. Ho, Robert T. Schooley, Donna Felsenstein, Charla Andrews and Robert C. Moellering and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

J. Davis Allan

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome

1985 836 citations David D. Ho, T R Rota et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Davis Allan United States	14	830	620	417	242	181	26	1.3k
Ray P. Brettle United Kingdom	27	772 0.9×	1.0k 1.6×	757 1.8×	249 1.0×	362 2.0×	66	1.9k
Sibyl P. M. Geelen Netherlands	28	664 0.8×	1.0k 1.7×	553 1.3×	262 1.1×	206 1.1×	59	1.9k
S. A. Danner Netherlands	21	1.7k 2.0×	1.4k 2.2×	636 1.5×	551 2.3×	352 1.9×	46	2.6k
E. Randall Lanier United States	24	1.4k 1.6×	1.3k 2.1×	512 1.2×	133 0.5×	263 1.5×	39	1.9k
Allen McCutchan United States	17	457 0.6×	542 0.9×	348 0.8×	180 0.7×	146 0.8×	27	1.2k
Parunag Nishanian United States	20	996 1.2×	651 1.1×	468 1.1×	724 3.0×	145 0.8×	27	1.8k
Gabriel Catano United States	19	615 0.7×	761 1.2×	486 1.2×	402 1.7×	76 0.4×	27	1.3k
Angela M. Amedee United States	26	1.2k 1.5×	842 1.4×	647 1.6×	526 2.2×	190 1.0×	65	2.1k
Sonya L. Heath United States	20	635 0.8×	391 0.6×	328 0.8×	682 2.8×	152 0.8×	70	1.3k
J. Craske United Kingdom	17	287 0.3×	333 0.5×	727 1.7×	237 1.0×	42 0.2×	36	1.4k

Countries citing papers authored by J. Davis Allan

Since Specialization

Citations

This map shows the geographic impact of J. Davis Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Davis Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Davis Allan more than expected).

Fields of papers citing papers by J. Davis Allan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Davis Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Davis Allan. The network helps show where J. Davis Allan may publish in the future.

Co-authorship network of co-authors of J. Davis Allan

This figure shows the co-authorship network connecting the top 25 collaborators of J. Davis Allan. A scholar is included among the top collaborators of J. Davis Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Davis Allan. J. Davis Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gilmore, Norbert, et al.. (2003). Interleukin‐7 levels may predict virological response in advanced HIV‐1‐infected patients receiving lopinavir/ritonavir‐based therapy. HIV Medicine. 4(4). 315–320. 16 indexed citations

2.

Fischl, Margaret A., Kenneth Stanley, Ann C. Collier, et al.. (1995). Combination and Monotherapy with Zidovudine and Zalcitabine in Patients with Advanced HIV Disease. Annals of Internal Medicine. 122(1). 24–32. 81 indexed citations

3.

Allan, J. Davis. (1994). Splenic abscess: pathogenesis, clinical features, diagnosis, and treatment.. PubMed. 14. 23–51. 12 indexed citations

4.

Allan, J. Davis, et al.. (1993). Long-Term Follow-Up of Didanosine Administered Orally Twice Daily to Patients with Advanced Human Immunodeficiency Virus Infection and Hematologic Intolerance of Zidovudine. Clinical Infectious Diseases. 16(Supplement_1). S46–S51. 19 indexed citations

5.

McLaren, C., Marcel Rozencweig, Mohan Beltangady, et al.. (1993). Longitudinal Analysis of Responses to Oral Didanosine Therapy Following Zidovudine Therapy in Advanced Infection with Human Immunodeficiency Virus. Clinical Infectious Diseases. 16(Supplement_1). S32–S39. 3 indexed citations

6.

Sekigawa, Iwao, et al.. (1991). Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clinical Immunology and Immunopathology. 58(1). 145–153. 39 indexed citations

7.

Connolly, Kevin, et al.. (1991). Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine. The American Journal of Medicine. 91(5). 471–478. 53 indexed citations

8.

Okayama, Akira, Bette Korber, Yi‐Ming Chen, et al.. (1991). Unusual pattern of antibodies to human T-cell leukemia virus type-I in family members of adult T-cell leukemia patients. Blood. 78(12). 3323–3329. 13 indexed citations

9.

Murphy, Robert L., James P. Lavelle, J. Davis Allan, et al.. (1991). Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: Results of a blinded dose-comparison study using an ultrasonic nebulizer. The American Journal of Medicine. 90(4). 418–426. 12 indexed citations

10.

Okayama, Akira, Bette Korber, Yi‐Ming Chen, et al.. (1991). Unusual pattern of antibodies to human T-cell leukemia virus type-I in family members of adult T-cell leukemia patients. Blood. 78(12). 3323–3329. 1 indexed citations

11.

Groopman, Jerome E., Patricia Benz, R.A. Ferriani, et al.. (1987). Characterization of Serum Netralization Response to the Human Immunodeficiency Virus (HIV). AIDS Research and Human Retroviruses. 3(1). 71–85. 51 indexed citations

12.

Allan, J. Davis, J E Coligan, Tzong‐Huei Lee, et al.. (1987). Immunogenic nature of a Pol gene product of HTLV-III/LAV. Blood. 69(1). 331–333. 31 indexed citations

13.

Allan, J. Davis. (1987). Antibiotic Combinations. Medical Clinics of North America. 71(6). 1079–1091. 6 indexed citations

14.

Ho, David D., T R Rota, Robert T. Schooley, et al.. (1987). Isolation of HTLV-III from CSF and neural tissues of patients with AIDS-related neurological syndromes. Annales de l Institut Pasteur Virologie. 138(1). 137–144. 7 indexed citations

15.

Moellering, R C, George M. Eliopoulos, & J. Davis Allan. (1986). Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.. PubMed. 80(5C). 30–4. 16 indexed citations

16.

Allan, J. Davis & Robert C. Moellering. (1985). Management of Infections Caused by Gram-Negative Bacilli: The Role of Antimicrobial Combinations. Clinical Infectious Diseases. 7(Supplement_4). S559–S571. 45 indexed citations

17.

Essex, Max, et al.. (1985). Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.. PubMed. 45(9 Suppl). 4534s–4538s. 13 indexed citations

18.

Allan, J. Davis & Robert C. Moellering. (1985). Antimicrobial combinations in the therapy of infections due to gram-negative bacilli. The American Journal of Medicine. 78(2). 65–76. 17 indexed citations

19.

Ho, David D., T R Rota, Robert T. Schooley, et al.. (1985). Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 313(24). 1493–1497. 836 indexed citations breakdown →

20.

Cabot, Richard C., Robert E. Scully, Eugene J. Mark, et al.. (1983). Case 36-1983. New England Journal of Medicine. 309(10). 600–606. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact